等待开盘 03-26 09:30:00 美东时间
+0.740
+3.37%
Revolve Group ( ($RVLV) ) has provided an update. On March 18, 2026, Revolve Gr...
03-20 21:36
Revolve Group director Erinn Elisabeth Murphy files initial beneficial ownership statement Revolve reported that director Erinn Murphy filed an initial Form 3 statement of beneficial ownership. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intellig
03-20 21:10
Revolve Group appoints Erinn Murphy to board as audit committee chair Revolve appointed Erinn Murphy to its board, effective immediately. Murphy was named chair of the audit committee and joined the compensation committee. She has held finance leadership roles at Crocs since September 2023, most rec
03-20 21:00
Breckenridge Distillery, a leading Colorado-based craft distillery, has partnered with Cheba Hut to introduce their award-winning Bourbon Whiskey and Mountain Shot across 18 Colorado locations. The collaboration offers a unique way for guests to enjoy Breckenridge spirits with shot-and-a-beer specials, perfect for pairing with Cheba Hut's toasted subs. Mountain Shot, known for its bold chocolate-mint flavor, is available at select spots in Boulde...
03-18 11:00
Revolve Group launches REVOLVE Los Angeles fashion house Revolve Group Inc. has launched REVOLVE Los Angeles, its first eponymous fashion house, expanding its portfolio of in-house brands and capabilities. The debut collection will be available March 9 exclusively on REVOLVE and FWRD, with Bella Had
03-04 22:00
The latest announcement is out from Revolver Resources Holdings Ltd ( ($AU:RRR)...
03-03 16:24
Tilray Brands acquired key assets of BrewDog, including its global brand, UK brewing operations, and 11 strategic brewpubs, for £33 million. The acquisition is expected to generate ~$200 million in annual net revenue and ~$6-$8 million in adjusted EBITDA by 2027, with Tilray aiming to reach ~$1.2 billion in annualized revenue. BrewDog's assets will expand Tilray's global beverage platform and provide opportunities for growth in international mark...
03-02 15:17
今日重点评级关注:巴克莱:维持Vir Biotechnology"超配"评级,目标价从26美元升至30美元;巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从10美元升至11美元
02-26 09:30
华盛资讯2月26日讯,Revolve Group公布2025财年年度业绩,公司年度营收12.26亿美元,同比增长8.5%,归母净利润0.62亿美元,同比增长24.0%。
02-26 04:51